Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) was the recipient of unusually large options trading on Thursday. Stock traders purchased 21,124 put options on the company. This is an increase of approximately 260% compared to the typical daily volume of 5,875 put options.
Institutional Trading of Bath & Body Works
Several institutional investors and hedge funds have recently modified their holdings of the business. D1 Capital Partners L.P. acquired a new position in shares of Bath & Body Works during the 4th quarter worth approximately $109,797,000. FMR LLC increased its position in Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company's stock worth $80,315,000 after buying an additional 2,501,828 shares in the last quarter. Norges Bank acquired a new position in shares of Bath & Body Works in the fourth quarter worth $73,572,000. Arrowstreet Capital Limited Partnership lifted its position in shares of Bath & Body Works by 79.1% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 3,882,047 shares of the company's stock valued at $150,507,000 after acquiring an additional 1,715,096 shares in the last quarter. Finally, KBC Group NV boosted its stake in shares of Bath & Body Works by 9,023.5% during the third quarter. KBC Group NV now owns 1,701,813 shares of the company's stock valued at $54,322,000 after acquiring an additional 1,683,160 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.
Analysts Set New Price Targets
Several analysts have commented on the company. Citigroup raised Bath & Body Works from a "neutral" rating to a "buy" rating and upped their price objective for the company from $40.00 to $48.00 in a research note on Friday. Piper Sandler upped their price target on Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a research note on Monday, January 6th. Wells Fargo & Company raised Bath & Body Works from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Morgan Stanley dropped their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating on the stock in a research note on Thursday, November 21st. Finally, Raymond James restated an "outperform" rating and issued a $46.00 target price (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Five research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat.com, Bath & Body Works currently has a consensus rating of "Moderate Buy" and an average target price of $45.06.
View Our Latest Stock Report on BBWI
Bath & Body Works Trading Down 2.3 %
Shares of NYSE:BBWI traded down $0.85 during trading on Monday, hitting $35.38. 6,003,122 shares of the stock were exchanged, compared to its average volume of 3,816,168. The company has a market cap of $7.66 billion, a PE ratio of 8.63, a P/E/G ratio of 0.92 and a beta of 1.83. The company has a fifty day moving average price of $37.70 and a two-hundred day moving average price of $34.15. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Equities research analysts anticipate that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works declared that its Board of Directors has initiated a share repurchase program on Thursday, February 27th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to buy up to 6.4% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's management believes its stock is undervalued.
Bath & Body Works Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be paid a $0.20 dividend. The ex-dividend date is Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.26%. Bath & Body Works's payout ratio is 21.98%.
Bath & Body Works Company Profile
(
Get Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.